/
/
/

Trident Texofab Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Sep 2017
₹26 Cr₹34 Cr₹26 Cr₹31 Cr₹28 Cr₹38 Cr₹32 Cr₹26 Cr₹26 Cr₹30 Cr₹23 Cr₹23 Cr₹23 Cr₹24 Cr₹25 Cr₹24 Cr₹23 Cr₹25 Cr₹24 Cr₹21 Cr₹15 Cr₹19 Cr₹14 Cr₹16 Cr₹1 Cr₹22 Cr₹20 Cr₹22 Cr₹26 Cr₹32 Cr₹17 Cr₹18 Cr₹21 Cr₹36 Cr
₹19 L₹53 L₹48 L₹39 L₹44 L₹48 L-₹26 L₹3 Cr₹86 L₹5 L₹11 L₹1 Cr₹8 L₹89 L₹74 L₹14 L₹13 L₹35 L₹2 L₹26 L₹11 L₹1 Cr₹4 L₹25 L₹8 L₹17 L₹7 L₹8 L₹8 L₹10 L₹9 L₹23 L₹8 L₹24 L
₹26 Cr₹34 Cr₹26 Cr₹31 Cr₹29 Cr₹39 Cr₹31 Cr₹29 Cr₹27 Cr₹30 Cr₹23 Cr₹24 Cr₹23 Cr₹25 Cr₹25 Cr₹24 Cr₹24 Cr₹25 Cr₹24 Cr₹21 Cr₹15 Cr₹21 Cr₹14 Cr₹16 Cr₹1 Cr₹23 Cr₹20 Cr₹22 Cr₹26 Cr₹32 Cr₹17 Cr₹18 Cr₹21 Cr₹36 Cr
₹25 Cr₹35 Cr₹25 Cr₹29 Cr₹26 Cr₹37 Cr₹30 Cr₹27 Cr₹25 Cr₹30 Cr₹22 Cr₹22 Cr₹22 Cr₹24 Cr₹23 Cr₹22 Cr₹22 Cr₹24 Cr₹23 Cr₹20 Cr₹14 Cr₹18 Cr₹13 Cr₹15 Cr₹1 Cr₹21 Cr₹19 Cr₹21 Cr₹25 Cr₹31 Cr₹16 Cr₹17 Cr₹20 Cr₹35 Cr
₹2 Cr-₹56 L₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹88 L₹100 L₹29 L₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹68 L₹1 Cr₹60 L₹62 L
₹55 L₹37 L₹87 L₹96 L₹73 L₹99 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹93 L₹1 Cr₹91 L₹1 Cr₹92 L₹84 L₹86 L₹47 L₹66 L₹91 L₹79 L₹81 L₹57 L₹74 L₹63 L₹83 L₹1 Cr₹81 L₹79 L₹44 L₹29 L₹48 L₹36 L₹33 L
₹69 L-₹2 Cr₹74 L₹2 Cr₹1 Cr₹38 L₹33 L₹95 L₹92 L-₹14 L₹67 L₹81 L-₹17 L-₹16 L₹2 Cr₹1 Cr₹32 L₹30 L₹57 L₹27 L₹14 L₹1 Cr₹11 L₹1 L-₹59 L₹55 L₹25 L₹24 L₹29 L₹73 L₹25 L₹39 L₹25 L₹23 L
₹52 L-₹2 Cr₹57 L₹1 Cr₹1 Cr₹51 L₹30 L₹1 Cr₹70 L-₹10 L₹56 L₹75 L-₹13 L₹6 L₹1 Cr₹78 L₹24 L₹67 L₹15 L₹2 L₹15 L₹86 L₹8 L-₹2 L-₹54 L₹34 L₹23 L₹14 L₹14 L₹73 L₹25 L₹35 L₹16 L₹16 L

Share Price Live Stats

Open (₹)21.70
Volume (₹)23,390.00
High (₹)21.70
Upper Circuit22.17
Low (₹)20.50
Lower Circuit20.07
Prev Close21.12
52W High (₹)379.00
Price20.50
52W Low (₹)20.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)31.67 Cr
Div. Yield (%)0.00
PE Ratio152.27
Debt to Equity0.62
Price to Book5.50
Book Value31.77
EPS (TTM)0.14
Face Value10.00
ROE (%)8.46

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
PAGEIND-ANSE
KPRMILL-ANSE
WELSPUNLIV-ANSE
VTL-ANSE
ARVIND-ANSE
MANYAVAR-ANSE
PGIL-ANSE
ICIL-ANSE
SWANCORP-ANSE
GARFIBRES-ANSE
TTFL-XNSE
LTP
1W Low
1W High
Market cap (₹)
37408.1+1508.1 (4.20%)
35550
37656.20
41,646Cr
1116.35-24.95 (-2.19%)
1105
1145
38,856Cr
218.25+3.6 (1.68%)
214.50
233.15
21,134Cr
562.95-14.65 (-2.54%)
550
596.20
16,273Cr
567.65+15.25 (2.76%)
530.90
571.70
14,908Cr
512.95-32.25 (-5.92%)
512.95
550.65
12,917Cr
1270+123.05 (10.73%)
1131.20
1328.80
12,010Cr
452.45+4.7 (1.05%)
433.95
486.15
9,432Cr
294.5+0.1 (0.03%)
291.05
310.90
9,404Cr
773.1-47.25 (-5.76%)
770.90
822.75
7,690Cr
20.5+0.2 (0.99%)
20
22.19
32Cr

Key Highlights of Trident Texofab Ltd’s P&L

In 2025-03-31, Trident Texofab Ltd reported total revenue of ₹122.06Cr, compared with ₹99.48Cr in 2024-03-31, reflecting Trident Texofab Ltd turnover.

Depreciation was ₹1.65Cr and finance costs were ₹4.68Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹2.58Cr in 2025-03-31 as compared to ₹1.17Cr in 2024-03-31.

Net Profit (PAT) was ₹2.45Cr in 2025-03-31 compared with ₹1.08Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.85 in 2025-03-31, compared with ₹1.07 in 2024-03-31.